Evidence map›Paper›PMID 25963636›Full record

ReviewInternational journal of oncology2015

Death-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review).

Sara Steinmann, Kristina Scheibe, Katharina Erlenbach-Wuensch, Clemens Neufert, Regine Schneider-Stock

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sara SteinmannExperimental Tumorpathology, Institute of Pathology, FAU Erlangen-Nürnberg, 91054 Erlangen, Germany.
Kristina ScheibeDepartment of Medicine 1, University Hospital Erlangen, FAU Erlangen-Nürnberg, Kussmaul Campus for Medical Research, 91052 Erlangen, Germany.
Katharina Erlenbach-WuenschInstitute of Pathology, FAU Erlangen-Nürnberg, 91054 Erlangen, Germany.
Clemens NeufertDepartment of Medicine 1, University Hospital Erlangen, FAU Erlangen-Nürnberg, Kussmaul Campus for Medical Research, 91052 Erlangen, Germany.
Regine Schneider-StockExperimental Tumorpathology, Institute of Pathology, FAU Erlangen-Nürnberg, 91054 Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversitätsklinikum Erlangen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytoskeleton-associated serine/threonine kinase death-associated protein kinase (DAPK) has been described as a cancer gene chameleon with functional antagonistic duality in a cell type and context specific manner. The broad range of interaction partners and substrates link DAPK to inflammatory processes especially in the gut. Herein we summarize our knowledge on the role of DAPK in different cell types that play a role under inflammatory conditions in the gut. Besides some promising experimental data suggesting DAPK as an interesting drug target in inflammatory bowel disease there are many open questions regarding direct evidence for a role of DAPK in intestinal inflammation.

Indexed as

AnimalsAnti-Inflammatory AgentsCell DeathColonic NeoplasmsDeath-Associated Protein KinasesGastrointestinal TractHumansInflammatory Bowel DiseasesAnti-Inflammatory AgentsDAPK1 protein, humanDeath-Associated Protein Kinases

Identifiers

PMID25963636
PMCPMC4485655
OpenAlexW1513261203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.